PhRMA: Roughly 400 new meds in pipeline for infectious diseases

America's biopharmaceutical research companies this year have 395 new medicines and vaccines in the pipeline to fight infectious diseases. Some of the diseases targeted plague the developing world, while others threaten lives in every country. Six medicines and five vaccines for malaria are currently in development, according to a PhRMA report. Of the 395 medicines and vaccines, 24 are on a fast track--including those for hepatitis C, severe sepsis and pneumonia. PhRMA release | Report

Suggested Articles

PureTech Health has decamped from Cambridge to Boston’s Seaport neighborhood as a step toward growing the company and ramping up its pipeline.

In this week's EuroBiotech Report, Sanofi cuts staff in R&D rejig, AstraZeneca bets on Korea and uniQure weighs buyout bids.

In our EuroBiotech roundup this week, BioNTech and Genmab start cancer trial, Oncopeptides posts cancer data and F-star hires CFO.